Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide 20 mcg in Postmenopausal Osteoporosis
NCT00532207Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Nov 2003; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00532207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532207.